Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes

Microbes and Infection

Volumn 6, Issue 5, 2004, Pages 485-493

  Tanaka, Michiko ^a   Kodaira, Hiroshi ^b   Nishiyama, Yukihiro ^c   Sata, Tetsutaro ^a   Kawaguchi, Yasushi ^c,d  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

ACV; Acyclovir; Anti viral agents; Bromodeoxyuridine; BudR; DMEM; Dulbecco's modified Eagle medium; FCS; Fetal calf serum; Fluorescent unit; FU; Ganciclovir; GCV; GFP; Green fluorescence protein; Green fluorescent protein; Herpes simplex virus; HSV; MOI; Simplex virus

Indexed keywords

ANTIVIRUS AGENT; EARLY GROWTH RESPONSE FACTOR 1; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; SPACER DNA;

ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BIOASSAY; BIOLOGICAL MONITORING; CONTROLLED STUDY; DRUG SCREENING; FLUORESCENCE; GENE CASSETTE; GENE CONSTRUCT; GENE CONTROL; GENE INSERTION; GENE LOSS; GENE REPLICATION; HERPES SIMPLEX VIRUS 1; IC 50; IN VITRO STUDY; IN VIVO CULTURE; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VERO CELL; VIRUS CULTURE; VIRUS GENE; VIRUS RECOMBINANT; VIRUS STRAIN; WILD TYPE;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DNA, INTERGENIC; FLUORESCENCE; GANCICLOVIR; GENE EXPRESSION REGULATION, VIRAL; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 1, HUMAN; LUMINESCENT PROTEINS; MICROBIAL SENSITIVITY TESTS; PLAQUE ASSAY; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; TRANSFECTION; VERO CELLS; VIRUS REPLICATION;

CICONIIFORMES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 1942421203     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.01.011     Document Type: Article

References (36)

1. Montgomery R.I., Warner M.S., Lum B.J., Spear P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87:1996;427-436.
2. Savatier N., Rocancourt D., Bonnerot C., Nicolas J.F. A novel system for screening antiretroviral agents. J. Virol. Methods. 26:1989;229-235.
3. Green B.J., Rasko J.E. Rapid screening for high-titer retroviral packaging cell lines using an in situ fluorescence assay. Hum. Gene. Ther. 13:2002;1005-1013.
4. Jarmy G., Heinkelein M., Weissbrich B., Jassoy C., Rethwilm A. Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system. J. Med. Virol. 64:2001;223-231.
5. Whitley R.J. Herpes simplex viruses. Knipe D.M., Howly P.M. Fields Virology. 2001;2461-2509 Lippincott-Williams & Wilkins, Philadelphia.
6. Mommeja-Marin H., Lafaurie M., Scieux C., Galicier L., Oksenhendler E., Molina J.M. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin. Infect. Dis. 37:2003;1527-1533.
7. Whitley R.J., Roizman B. Herpes simplex virus infections. Lancet. 357:2001;1513-1518.
8. Christophers J., Clayton J., Craske J., Ward R., Collins P., Trowbridge M., Darby G. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob. Agents. Chemother. 42:1998;868-872.
9. Morfin F., Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J. Clin. Virol. 26:2003;29-37.
10. Gilbert C., Bestman-Smith J., Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug. Resist. Updat. 5:2002;88-114.
11. Safrin S., Crumpacker C., Chatis P., Davis R., Hafner R., Rush J., Kessler H.A., Mills J. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N. Engl. J. Med. 325:1991;551-555.
12. Saijo M., Yasuda Y., Yabe H., Kato S., Suzutani T., De Clercq E., Niikura M., Maeda A., Kurane I., Morikawa S. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. J. Med. Virol. 68:2002;99-104.
13. Sarisky R.T., Quail M.R., Clark P.E., Nguyen T.T., Halsey W.S., Wittrock R.J., O'Leary Bartus J., Van Horn M.M., Sathe G.M., Van Horn S., Kelly M.D., Bacon T.H., Leary J.J. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. J. Virol. 75:2001;1761-1769.
14. Steele-Mortimer O.A., Meier-Ewert H., Loser R., Hasmann M.J. Flow cytometric analysis of virus-infected cells and its potential use for screening antiviral agents. J. Virol. Methods. 27:1990;241-252.
15. Sudo K., Konno K., Yokota T., Shigeta S. A sensitive assay system screening antiviral compounds against herpes simplex virus type 1 and type 2. J. Virol. Methods. 49:1994;169-178.
16. Tsien R.Y. The green fluorescent protein. Annu. Rev. Biochem. 67:1998;509-544.
17. Adler H., Messerle M., Koszinowski U.H. Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences. J. Virol. 75:2001;5692-5696.
18. Smith G.A., Enquist L.W. Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J. Virol. 73:1999;6405-6414.
19. Tanaka M., Kagawa H., Yamanashi Y., Sata T., Kawaguchi Y. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J. Virol. 77:2003;1382-1391.
20. Baines J.D., Roizman B. The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture. J. Virol. 65:1991;938-944.
21. Ejercito P.M., Kieff E.D., Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. Gen. Virol. 2:1968;357-364.
22. Post L.E., Mackem S., Roizman B. Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. Cell. 24:1981;555-565.
23. He B., Chou J., Liebermann D.A., Hoffman B., Roizman B. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70:1996;84-90.
24. Kawaguchi Y., Van Sant C., Roizman B. Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J. Virol. 71:1997;7328-7336.
25. Kawaguchi Y., Tanaka M., Yokoymama A., Matsuda G., Kato K., Kagawa H., Hirai K., Roizman B. Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. Proc. Natl. Acad. Sci. USA. 98:2001;1877-1882.
26. Koyano S., Suzutani T., Yoshida I., Azuma M. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes. Antimicrob. Agents. Chemother. 40:1996;920-923.
27. Kawaguchi Y., Bruni R., Roizman B. Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J. Virol. 71:1997;1019-1024.
28. Tanaka M., Yokoyama A., Igarashi M., Matsuda G., Kato K., Kanamori M., Hirai K., Kawaguchi Y., Yamanashi Y. Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association. J. Virol. 76:2002;1025-1032.
29. Andreansky S., He B., van Cott J., McGhee J., Gillespie G.Y., Roizman B., Whitley R.J. Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene. Ther. 5:1998;121-130.
30. Advani S.J., Brandimarti R., Weichselbaum R.R., Roizman B. The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes. J. Virol. 74:2000;8-15.
31. Cocchi F., Menotti L., Mirandola P., Lopez M., Campadelli-Fiume G. The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J. Virol. 72:1998;9992-10002.
32. Lorentzen E.U., Eing B.R., Hafezi W., Manservigi R., Kuhn J.E. Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein. Intervirology. 44:2001;232-242.
33. Desai P., Person S. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J. Virol. 72:1998;7563-7568.
34. Potel C., Kaelin K., Gautier I., Lebon P., Coppey J., Rozenberg F. Incorporation of green fluorescent protein into the essential envelope glycoprotein B of herpes simplex virus type 1. J. Virol. Methods. 105:2002;13-23.
35. Donnelly M., Elliott G. Fluorescent tagging of herpes simplex virus tegument protein VP13/14 in virus infection. J. Virol. 75:2001;2575-2583.
36. Elliott G., O'Hare P. Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J. Virol. 73:1999;4110-4119.